Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 4598-4601, October 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Przyborski, S. A.
Right arrow Articles by Ackerman, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Przyborski, S. A.
Right arrow Articles by Ackerman, S. L.

Differential Expression of the Zinc Finger Gene TCF17 in Testicular Tumors1

Stefan A. Przyborski, Ivan Damjanov, Barbara B. Knowles and Susan L. Ackerman2

The Jackson Laboratory, Bar Harbor, Maine 04609 [S. A. P., B. B. K., S. L. A.], and Department of Pathology and Laboratory Medicine, Kansas City, Kansas 66160 [I. D.]

TCF17, the human homologue of the rat zinc finger gene Kid1, is highly expressed in neurons derived from the retinoic acid-treated human embryonal carcinoma (EC) cell line, NTERA-2. This differentiation-related up-regulation of TCF17 prompted us to investigate its expression during human spermatogenesis and in human testicular germ cell tumors considered to be precursors of EC. Expression of TCF17 increases as spermatogonia differentiate into spermatocytes, indicating that this gene is developmentally regulated during spermatogenesis. TCF17 mRNA levels are high in carcinoma in situ and in seminoma, a tumor derived from carcinoma in situ but still of low-grade malignancy. However, TCF17 expression is decreased in highly malignant EC. The differential regulation of TCF17 during neoplastic germ cell differentiation may be of predictive value in germ cell tumor diagnosis.

1 This work was supported by Grant NS35900 (to S. L. A.) and Grant CA37225 (to B. B. K.) from the NIH and CORE Grant CA34196 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609. Phone: (207) 288-6494; Fax: (207) 288-6077; E-mail: sla@jax.org.

Received 7/17/98. Accepted 9/ 1/98.




This article has been cited by other articles:


Home page
BloodHome page
I. Gomes, T. T. Sharma, S. Edassery, N. Fulton, B. G. Mar, and C. A. Westbrook
Novel transcription factors in human CD34 antigen-positive hematopoietic cells
Blood, June 17, 2002; 100(1): 107 - 119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.